Eduardo Olavarria

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis.

Jaspal Kaeda, D. Marin, J. Goldman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase.

Katayoun Rezvani, Holger W Auner, K. Rezvani, 2010, Blood.